« Return to News | Clinical Intelligence

Biogen Idec, GNS target personalized medicine

Thursday, March 17, 2011 11:53 AM

Using a patient dataset and high-horsepower computing, researchers at Biogen Idec and analytics company GNS Healthcare have built a rheumatoid arthritis disease model that lets them run patient-specific virtual clinical trials, according to Fierce Biotech IT. This personalized-medicine stepping stone yields dynamic disease models of individualized patient outcomes.

The model generates predictions of the RA-sufferer's response to drugs, and the response to inhibiting drug targets and disease pathways. That's a first, said Colin Hill, CEO at GNS.

The collaborators used a patient dataset comprising genotyping, whole-blood gene expression profiles and such clinical measures as tender joints, swollen joints and C-reactive protein. They fed the data into GNS's supercomputer-driven platform, REFS (reverse-engineering and forward-simulation). REFS built the model.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.